Search results for "DOPAMINE"

showing 10 items of 660 documents

Simultaneous determination of levodopa methyl ester, levodopa, 3-O-methyldopa and dopamine in plasma by high-performance liquid chromatography with e…

1994

A new procedure is described for the simultaneous determination of levodopa methyl ester (LDME) and its biotransformation products levodopa (L-DOPA), 3-O-methyldopa (3-OMD) and dopamine (DA) in stabilized plasma samples, using reversed-phase high-performance liquid chromatography. A coulometric detector equipped with a dual-electrode system operating in the redox mode was used to simultaneously quantitate all compounds. This system generated a double signal monitored by a dual-channel acquisition data system and allowed quantitation of compounds at the nanogram level. The intra- and inter-assay precision varied in the 2.4-6.9% and 3.2-9.1% ranges respectively, whereas the recoveries were cl…

LevodopaChromatographyChemistryMetaboliteDopamineGeneral ChemistryReversed-phase chromatographyHigh-performance liquid chromatographyRatsCoulometryLevodopachemistry.chemical_compoundPharmacokineticsmedicineElectrochemistryAnimalsHumansTyrosine3-O-MethyldopaQuantitative analysis (chemistry)Oxidation-ReductionChromatography High Pressure Liquidmedicine.drugJournal of chromatography. B, Biomedical applications
researchProduct

Potential dopamine prodrug-loaded liposomes: preparation, characterization, andin vitrostability studies

2010

Dopamine delivery to the central nervous system (CNS) undergoes the permeability limitations of the blood-brain barrier (BBB). Condensation of dopamine with neutral amino acids could afford potential pro- drugs able to interact with the BBB endogenous transporters and easily enter the brain. To improve the bio-availability of the dopamine prodrug, 2-amino-N-[2-(3,4-dihydroxy-phenyl)-ethyl]-3-phenyl-propionamide (DOPH), it was encapsulated in unilamellar liposomes of dimiristoylphosphatidylcholine (DMPC)and cholesterol. Vesicles were characterized by dynamic light scattering in order to evaluate their dimensions and vesicle stability, by zeta-potential measurements, by means of electronic mi…

LightDopaminePhenylalanineenzymatic stabilityPharmaceutical Sciencechemical stability; dopamine prodrug; enzymatic stability; liposomeschemical stabilityDrug StabilityDynamic light scatteringDopamineZeta potentialmedicineHumansScattering RadiationProdrugsLiposomeChromatographyCalorimetry Differential ScanningChemistryVesicleProdrugSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoPermeability (electromagnetism)LiposomesliposomeBiophysicsChemical stabilityDimyristoylphosphatidylcholineDopamine prodrugmedicine.drugJournal of Liposome Research
researchProduct

Association of ADHD with genetic variants in the 5'-region of the dopamine transporter gene: evidence for allelic heterogeneity.

2008

Contains fulltext : 69953.pdf (Publisher’s version ) (Closed access) Multiple studies have reported an association between attention deficit hyperactivity disorder (ADHD) and the 10-repeat allele of a variable number tandem repeat (VNTR) polymorphism in the 3'-untranslated region (3'UTR) of the dopamine transporter gene (DAT1). Yet, recent meta-analyses of available data find little or no evidence for this association; although there is strong evidence for heterogeneity between datasets. This pattern of findings could arise for several reasons including the presence of relatively rare risk alleles on common haplotype backgrounds or the functional interaction of two or more loci within the g…

Linkage disequilibriumGenetics and epigenetic pathways of disease [NCMLS 6]Medizin2804 Cellular and Molecular NeuroscienceNeuroinformatics [DCN 3]Linkage Disequilibrium2738 Psychiatry and Mental Health0302 clinical medicineGene FrequencyRisk FactorsPerception and Action [DCN 1]Genetics(clinical)Promoter Regions GeneticGenetics (clinical)Genetics0303 health sciences10058 Department of Child and Adolescent PsychiatryEuropeVariable number tandem repeatPsychiatry and Mental health/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingAllelic heterogeneityFunctional Neurogenomics [DCN 2]Genetic Markers2716 Genetics (clinical)Single-nucleotide polymorphism610 Medicine & healthBiologyPolymorphism Single NucleotideMental health [NCEBP 9]White PeopleGenomic disorders and inherited multi-system disorders [IGMD 3]Genetic Heterogeneity03 medical and health sciencesCellular and Molecular NeuroscienceSDG 3 - Good Health and Well-beingCognitive neurosciences [UMCN 3.2]Humansddc:610Medizinische Fakultät » Universitätsklinikum Essen » LVR-Klinikum Essen » Klinik für Psychiatrie Psychosomatik und Psychotherapie des Kindes- und JugendaltersAlleleAllele frequencyAlleles030304 developmental biologyDopamine Plasma Membrane Transport ProteinsGenetic heterogeneityHaplotypeGenetic VariationHaplotypesGenetic defects of metabolism [UMCN 5.1]Attention Deficit Disorder with Hyperactivity5' Untranslated Regions030217 neurology & neurosurgeryMicrosatellite Repeats
researchProduct

Neuronal activity triggers uptake of hematopoietic extracellular vesicles in vivo

2019

Communication with the hematopoietic system is a vital component of regulating brain function in health and disease. Traditionally, the major routes considered for this neuroimmune communication are by individual molecules such as cytokines carried by blood, by neural transmission, or, in more severe pathologies, by the entry of peripheral immune cells into the brain. In addition, functional mRNA from peripheral blood can be directly transferred to neurons via extracellular vesicles (EVs), but the parameters that determine their uptake are unknown. Using varied animal models that stimulate neuronal activity by peripheral inflammation, optogenetics, and selective proteasome inhibition of dop…

LipopolysaccharidesMaleGene ExpressionStimulationHippocampusBiochemistryStereotaxic Techniques0302 clinical medicineShort ReportsAnimal CellsMedicine and Health SciencesPremovement neuronal activityBiology (General)Routes of AdministrationNeurons0303 health sciencesBrain MappingKainic AcidBrainAnimal ModelsPeripheralCell biologyHaematopoiesisBioassays and Physiological AnalysisExperimental Organism SystemsHippocampus ; Yellow flourescent protein ; Intravenous injections ; Marker genes ; Gene expression ; Neurons ; Microglial cells ; OptogeneticsFemaleCellular TypesSignal TransductionProteasome Endopeptidase ComplexQH301-705.5Yellow Fluorescent ProteinMice TransgenicGlial CellsMouse ModelsStimulus (physiology)BiologyResearch and Analysis Methods03 medical and health sciencesExtracellular VesiclesImmune systemModel OrganismsIn vivoIntravenous InjectionsGeneticsAnimalsddc:610Molecular Biology TechniquesMolecular BiologyMicroglial Cells030304 developmental biologyInflammationPharmacologyMessenger RNABlood CellsUbiquitinDopaminergic NeuronsBiology and Life SciencesProteinsMarker GenesCell BiologyNeurophysiological AnalysisOptogeneticsLuminescent ProteinsCellular NeuroscienceAnimal Studies030217 neurology & neurosurgeryNeuroscience
researchProduct

Synthesis and in vitro studies on a potential dopamine prodrug.

2008

Dopamine delivery to the central nervous system (CNS) undergoes the permeability limitations of blood-brain barrier (BBB) which is a selective interface that excludes most water-soluble molecules from entering the brain. Neutral amino acids permeate the BBB by specific transport systems. Conden- sation of dopamine with neutral amino acids could afford potential prodrugs able to interact with the BBB endogenous transporters and easily enter the brain. The synthesis and characterization of the dopamine derivative 2-amino-N-[2-(3,4-dihydroxy-phenyl)-ethyl]-3-phenyl-propionamide (7) is de- scribed. The chemical and enzymatic stability of 7 was evaluated. The molecular weight (300 Da) and Log P …

Magnetic Resonance SpectroscopyChemistry PhysicalDopamineenzymatic stabilityMembranes ArtificialBuffersSettore CHIM/08 - Chimica FarmaceuticaRatschemical stabilityRats Sprague-DawleyDrug Delivery SystemsSolubilitySettore CHIM/09 - Farmaceutico Tecnologico ApplicativoDopamine ProdrugAnimalsHumansIndicators and ReagentsProdrugsIntestinal MucosaDie Pharmazie
researchProduct

Synthesis and characterization of biotinylated and photoactivatable neuroleptics. Novel bifunctional probes for dopamine receptors

1992

Abstract We have synthesized and characterized a series of novel derivatives of established antagonists of the neurotransmitter dopamine, i.e. butyrophenones, hexahydrocarbolines and phenothiazenes. All derivatives were biotinylated, some of them carried an additional (photoactivatable) azido group. In the case of butyrophenones, the structural modifications were introduced at the aliphatic keto group and/or the heterocyclic ring system, both modifications resulting in significant decreases in binding affinity to dopamine D 2 and dopamine D 1 receptor subtypes. Biotinylation of hexahydrocarbolines significantly increased their binding affinity to D 1 receptors, with the affinity for D 2 rec…

Magnetic Resonance SpectroscopySpectrophotometry InfraredPhotochemistryButyrophenoneStereochemistryBiotinIn Vitro TechniquesLigandsBinding CompetitiveReceptors DopamineStructure-Activity Relationship03 medical and health scienceschemistry.chemical_compound0302 clinical medicineDopaminemedicineAnimalsNeurotransmitterReceptor030304 developmental biologyPharmacology0303 health sciencesDopamine antagonistAffinity LabelsBenzazepineschemistryBiochemistrySpiperoneDopamine receptorBiotinylationCattleButyrophenones030217 neurology & neurosurgeryAntipsychotic Agentsmedicine.drugEuropean Journal of Pharmacology: Molecular Pharmacology
researchProduct

Obesity-associated deficits in inhibitory control are phenocopied to mice through gut microbiota changes in one-carbon and aromatic amino acids metab…

2021

Gut: first published.

Male0301 basic medicine2312MicrobiologiaGut floraTranscriptomeMice0302 clinical medicineOverweight persons1506Gut MicrobiotaPrefrontal cortexhealth care economics and organizationsdigestive oral and skin physiologyGastroenterologyIntestins -- MalaltiesFecal Microbiota TransplantationMiddle AgedPersones obesesserotonin3. Good healthInhibition PsychologicalIntestins -- MicrobiologiaPhenotypemedicine.anatomical_structureintestinal microbiology ; microbiota ; obesity.ObesitatFemaleIntestines -- DiseasesdopamineperformanceAdultmedicine.medical_specialtytryptophan depletionPhysical exerciseBiologyIntestines -- Microbiologydigestive systemMicrobiologyAmino Acids Aromatic03 medical and health sciencesMetabolomicsInternal medicinemedicineAnimalsHumansObesityAnterior cingulate cortexAgedIntestinal microbiologyMetabolismbiology.organism_classificationCarbonGastrointestinal MicrobiomeFatty LiverCross-Sectional Studies030104 developmental biologyEndocrinologyTranscriptome030217 neurology & neurosurgeryStroop effect
researchProduct

Sex Differences in the Neuroadaptations of Reward-related Circuits in Response to Subchronic Variable Stress

2018

Women are twice as likely to be diagnosed with major depressive disorder. However, fewer studies in rodent models of depression have used female animals, leading to a relative lack of understanding of the female brain’s response to stress, especially at a neural circuit level. In this study, we utilized a 6-day subchronic variable stress (SCVS) mouse model and measured novelty suppressed feeding as behavioral criteria to evaluate susceptibility to SCVS in male and female mice. First, we showed that SCVS induced a decrease in latency to eat (susceptible phenotype) in female mice, but not in males (resilient phenotype). After determining behavioral phenotypes, we investigated the firing activ…

Male0301 basic medicineAction Potentialsneuronal activityTissue Culture Techniques0302 clinical medicinePremovement neuronal activitylocus coeruleuNeuronsSex CharacteristicsNeuronal Plasticitymusculoskeletal neural and ocular physiologyGeneral NeuroscienceBrainPhenotypeVentral tegmental areamedicine.anatomical_structureMajor depressive disorderFemaleDisease Susceptibilitylateral habenulamedicine.drugmedicine.medical_specialtyCell typesex differenceventral tegmental areaBiologyArticle03 medical and health sciencesRewardDopamineInternal medicinemedicineAnimalsAction PotentialDepressive DisorderAnimalNeuronmedicine.diseaseMice Inbred C57BLElectrophysiology030104 developmental biologyEndocrinologynervous systemSettore BIO/14 - FarmacologiaLocus coeruleusTissue Culture Techniquemajor depressionStress Psychological030217 neurology & neurosurgeryNeuroscience
researchProduct

Early impairment of epigenetic pattern in neurodegeneration: Additional mechanisms behind pyrethroid toxicity

2019

Abstract Permethrin is a synthetic pyrethroid extensively used as anti-woodworm agent and for indoor and outdoor pest control. The main route of human exposure is through fruit, vegetable and milk intake. Low dosage exposure to permethrin during neonatal brain development (from postnatal day 6 to postnatal day 21) leads to dopamine decrease in rat striatum nucleus, oxidative stress and behavioural changes linked to the development of Parkinson's like neurodegeneration later in life. The aim of this study was to evaluate the expression of genes involved in the dopaminergic pathway and epigenetic regulatory mechanisms in adolescent rats treated with permethrin during neonatal brain developmen…

Male0301 basic medicineAgingDopamineStriatumPharmacologyBiologyBiochemistryEpigenesis GeneticMECP203 medical and health sciences0302 clinical medicineEndocrinologyDopamineNuclear Receptor Subfamily 4 Group A Member 2parasitic diseasesGeneticsmedicineAnimalsEpigeneticsRats WistarPromoter Regions GeneticDNA Modification MethylasesMolecular BiologyPermethrinOrphan receptorDopaminergicNeurodegenerationNeurodegenerative DiseasesCell BiologyDNA Methylationmedicine.diseaseCorpus StriatumRatsMolecular Docking Simulation030104 developmental biologyAnimals Newbornalpha-SynucleinProtein Multimerization030217 neurology & neurosurgeryPermethrinmedicine.drugExperimental Gerontology
researchProduct

Regional differences in mu-opioid receptor-dependent modulation of basal dopamine transmission in rat striatum

2016

Abstract The nigrostriatal dopamine system is implicated in the regulation of reward and motor activity. Dopamine (DA) release in dorsal striatum (DS) is controlled by the firing rate of DA neurons in substantia nigra pars compacta. However, influences at terminal level, such as those involving activation of mu opioid receptors (MORs), can play a key role in determining DA levels in striatum. Nonetheless, published data also suggest that the effect of opioid drugs on DA levels may differ depending on the DS subregion analyzed. In this study, in vivo microdialysis in rats was used to explore this regional dependence. Changes in basal DA levels induced by local retrodialysis application of DA…

Male0301 basic medicineAgonistmedicine.medical_specialtymedicine.drug_classDopamineMicrodialysisReceptors Opioid muSubstantia nigraStriatum03 medical and health scienceschemistry.chemical_compound0302 clinical medicineDopamineInternal medicinemedicineAnimalsRats WistarPars compactaGeneral NeuroscienceVentral striatumEnkephalin Ala(2)-MePhe(4)-Gly(5)-Corpus StriatumDAMGO030104 developmental biologyEndocrinologymedicine.anatomical_structurenervous systemchemistryμ-opioid receptorNeuroscience030217 neurology & neurosurgerymedicine.drugNeuroscience Letters
researchProduct